<DOC>
	<DOC>NCT00737841</DOC>
	<brief_summary>There has been no data on effect of Bifidobacterium breve on symptoms of patients with irritable bowel syndrome (IBS). We hypothesized that Bifidobacterium breve is effective on symptoms of IBS patients.</brief_summary>
	<brief_title>Effect of Bifidobacterium on Irritable Bowel Syndrome</brief_title>
	<detailed_description>There has been no data on effect of Bifidobacterium breve on symptoms of patients with irritable bowel syndrome (IBS). We hypothesized that Bifidobacterium breve is effective on symptoms of IBS patients. IBS patients will be enrolled via advertisement. Any IBS subtypes will not be rejected. They will take either 1.0 g of Bifidobacterium breve 3 times a day or same amount of placebo for 8 weeks. IBS symptoms and allied markers will be checked before, during, and after the administration.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Diagnosis of IBS with Rome II definition Diagnosis of serious diseases (both physically and mentally)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>stress</keyword>
	<keyword>brain-gut interactions</keyword>
	<keyword>visceral perception</keyword>
	<keyword>gastrointestinal motility</keyword>
	<keyword>emotion</keyword>
</DOC>